Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medullary thyroid carcinoma: long-term outcomes of surgical treatment.

Annals of surgical oncology - 1 Jan 2011

Abraham Deepak T, Low Tsu-Hui, Messina Marinella, Jackson Nicole, Gill Anthony, Chou Angela S, Delbridge Leigh, Learoyd Diana, Robinson Bruce G, Sidhu Stan, Sywak Mark

Abstract excerpt

BACKGROUND: Medullary thyroid carcinoma (MTC) accounts for 5 to 10% of all thyroid cancers but is responsible for a disproportionate number of deaths. METHODS: We performed a retrospective review to describe clinical outcomes in patients with medullary thyroid carcinoma, screening a subset of patients for somatic mutations in the RET and p18 genes and performing genotype-phenotype correlation in a tertiary-care...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcitonin
Share to Carcinoma, Neuroendocrine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p18

Share to Lymphatic Metastasis

Share to Proto-Oncogene Proteins c-ret

Share to Survival Rate

Share to Thyroid Neoplasms

Share to Thyroidectomy

Source

Identifiers

PMID: 20878247
DOI: 10.1245/s10434-010-1339-y

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medullary thyroid carcinoma: long-term outcomes of surgical treatment.PMID 20878247Read ↗

Medullary thyroid cancer: molecular factors, management and treatment.Semantic proximity Read ↗

Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence.Semantic proximity Read ↗

Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.Semantic proximity Read ↗

Sporadic and familial medullary thyroid carcinoma: state of the art.Semantic proximity Read ↗

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RETSemantic proximity Read ↗

Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma.Semantic proximity Read ↗

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.Semantic proximity Read ↗

Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma.Semantic proximity Read ↗

Medullary Thyroid Cancer: Molecular Biology and Novel Molecular TherapiesSemantic proximity Read ↗

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.Semantic proximity Read ↗

Hereditary medullary thyroid carcinoma: the management dilemma.Semantic proximity Read ↗

Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.